Elsevier

Atherosclerosis

Volume 194, Issue 2, October 2007, Pages e1-e8
Atherosclerosis

Insulin and adiponectin inhibit the TNFα-induced ADMA accumulation in human endothelial cells: The role of DDAH

https://doi.org/10.1016/j.atherosclerosis.2006.11.008Get rights and content

Abstract

Objective

Insulin and adiponectin exert important effects on the vasculature. We wanted to explore whether the eNOS inhibitor asymmetric dimethylarginine (ADMA) contribute to their effects.

Methods

Human umbilical vein endothelial cells (HUVECs) and human coronary artery endothelial cells (HCAECs) were incubated with growth medium in the presence or absence of tumor necrosis factor-alpha (TNFα), d-glucose, insulin or adiponectin. Further, cells exposed to TNFα for 24 h were co-stimulated with insulin or adiponectin for additional 24 h. Concentrations of ADMA in conditioned media and activity of dimethylarginine dimethylaminohydrolase (DDAH) in cell lysates were determined.

Results

The dose-dependent TNFα-induced ADMA accumulation was significantly inhibited when co-stimulated with insulin or adiponectin in both cell lines (p < 0.01 for all), accompanied by significant increases in DDAH activity in all conditions. Insulin alone resulted in a significant, but inversely dose-dependent accumulation of ADMA as compared to control cells in both cell lines, accompanied by increased DDAH activity. Adiponectin alone tended, dose-dependently to decrease ADMA, but without an increase of DDAH activity.

Conclusion

The results indicate that ADMA accumulation in human cultured endothelial cells is influenced by both insulin and adiponectin, and both mediators counteract the TNFα-induced accumulation of ADMA through the DDAH pathway.

Introduction

There is growing evidence that endothelial dysfunction, reflected by an impaired nitric oxide (NO)-mediated vasodilatation [1], is an early step in the development of atherosclerosis [2]. The endogenous NO synthase (NOS) inhibitor asymmetric dimethylarginine (ADMA) is associated with reduced NO production and impaired endothelium-dependent vasodilatation [3]. Plasma ADMA concentrations have been found significantly increased in a variety of disease entities, including patients with chronic renal diseases and hypercholesterolemia [3], [4], [5], [6], [7]. Previous studies have demonstrated that ADMA concentrations are strongly associated with components related to the metabolic syndrome [7], [8], in which the clustering of factors such as obesity, dyslipidaemia, hypertension and insulin resistance contributes to a substantial increase in the risk of cardiovascular diseases [9], [10].

Hyperinsulinemia is an important component of the metabolic syndrome, and there is evidence that insulin per se has important direct effects on the vasculature, exerting both vasodilating and vasoconstricting effects [11], [12]. However, the exact mechanisms by which insulin exerts its effect on the vasculature are still not fully understood, and whether hyperinsulinemia contributes to endothelial dysfunction in insulin resistance remains debatable.

Adiponectin is secreted by adipocytes, and mimics several metabolic effects of insulin. Plasma concentrations of adiponectin are reduced in obese humans, and decreased concentrations are associated with insulin resistance and hyperinsulinemia [13]. In addition, adiponectin seems to have antiatherogenic properties, and decreased concentrations have been demonstrated in patients with coronary artery disease [14]. However, the direct relationship between adiponectin and endothelial dysfunction has not yet been fully explored.

Whereas glucose has been found to be stimulatory to ADMA accumulation in human endothelial cells [15], no such data exist with regard to insulin. The present study was therefore designed to investigate whether the formation of ADMA in cultured human endothelial cells is directly influenced by insulin or adiponectin in the ranges of human physiological concentrations. As plasma concentrations of insulin has been strongly correlated to ADMA concentrations in chronic insulin resistance states [8], [16], but was shown to reduce ADMA concentrations during acute hyperinsulinemia [17], we hypothesised that insulin might exert either stimulating or suppressing effects on ADMA accumulation in cell cultures. Based on the strong association previously shown between ADMA and obesity, another hypothesis was that adiponectin would decrease the formation of ADMA. Our final hypothesis was that any effects of insulin and adiponectin on ADMA concentrations might be regulated by the activity of the degrading enzyme dimethylarginine dimethylaminohydrolase (DDAH).

Section snippets

Cell subculture preparation

Human umbilical vein endothelial cells (HUVECs), obtained from a caucasian female donor, and human coronary artery endothelial cells (HCAECs), obtained from a black male donor (Cambrex, Kerviers, Belgium, for both) were cultured according to the manufacturer's instructions and aliquoted in batches for use in the respective experiments. Briefly, the endothelial cells were seeded at a density of 5000 cells/cm2 and grown in endothelial basal medium (Cambrex) supplemented with human recombinant

Cell viability

Exposure of HCAECs and HUVECs to any of the stimulators at any concentrations did not influence cell viability (data not shown).

ADMA elaboration by endothelial cells

In both HCAECs and HUVECs, the concentration of ADMA in the conditioned medium of control cells increased with time from 3.0 ± 0.05 to 4.2 ± 0.1 (p < 0.01) and from 1.9 ± 0.04 to 3.1 ± 0.09 pmol/μg protein (p < 0.001), respectively, after 48 h. In response to TNFα, insulin and glucose significantly increased accumulation of ADMA in the conditioned medium was observed over time in

Discussion

In the present study our main findings were that in human cultured endothelial cells the TNFα-induced ADMA accumulation was markedly inhibited in the presence of insulin and adiponectin, both in a dose-dependent manner. These observations could be explained by changes in the endothelial DDAH activity. In accordance with the literature, our cell lines exposed to TNFα showed significant ADMA accumulation over time [18]. TNFα has a number of functions and reduced NO bioavailability in cultured

Acknowledgements

We want to thank Baard Birkenes and Theresa Mai for laboratory assistance.

Reference (38)

  • R. Ross

    The pathogenesis of atherosclerosis: a perspective for the 1990s

    Nature

    (1993)
  • E.M. Kurowska

    Nitric oxide therapies in vascular diseases

    Curr Pharm

    (2002)
  • R.H. Boger et al.

    Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia

    Circulation

    (1998)
  • P. Vallance et al.

    Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

    Lancet

    (1992)
  • V. Achan et al.

    Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase

    Arterioscler Thromb Vasc Biol

    (2003)
  • A. Fard et al.

    Acute elevations of plasma asymmetric dimethylarginine and impaired endothelial function in response to a high-fat meal in patients with type 2 diabetes

    Arterioscler Thromb Vasc Biol

    (2000)
  • M.C. Stuhlinger et al.

    Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor

    JAMA

    (2002)
  • G.M. Reaven

    Banting lecture 1988. Role of insulin resistance in human disease

    Diabetes

    (1988)
  • G.M. Reaven

    Insulin resistance/compensatory hyperinsulinemia, essential hypertension, and cardiovascular disease

    J Clin Endocrinol Metab

    (2003)
  • Cited by (43)

    • Antidiabetic drug metformin is effective on the metabolism of asymmetric dimethylarginine in experimental liver injury

      2014, Diabetes Research and Clinical Practice
      Citation Excerpt :

      In diabetes mellitus, hyperglycemia can activate proinflammatory cytokines such as tumor necrosis factor (TNF)-α that could impair endothelial function [10]. It has been shown that TNF-α inhibited DDAH activity in cultured human endothelial cells and promoted the accumulation of ADMA [11]. Furthermore, TNF-α was defined as the major mediator leading to liver injury following LPS/d-GalN injections [12].

    • Asymmetric dimethylarginine accumulates in the kidney during ischemia/reperfusion injury

      2014, Kidney International
      Citation Excerpt :

      Therefore, the present findings suggest that protein degradation rather than gene suppression might be involved in DDAH-1 reduction in the IR-injured kidney. As DDAH is downregulated by cytokines, including tumor necrosis factor-α, MG-132 may be increasing DDAH-1 by suppressing the inflammation.35,36 Several papers have reported that proteosomal inhibitors have a protective role against IR-induced renal dysfunction.37,38

    • Nitric oxide bioavailability and adiponectin production in chronic systolic heart failure: Relation to severity of cardiac dysfunction

      2013, Translational Research
      Citation Excerpt :

      In direct contrast to previous reports of an inverse correlation between plasma adiponectin and ADMA levels in the non-heart failure setting, our data indicate a direct correlation between plasma adiponectin and ADMA levels. Since increased adiponectin levels have been reported to attenuate the TNFα-mediated decrease in the activity of the ADMA degrading enzyme, dimethylarginine dimethylaminohydrolase,6,7 our data imply that natriuretic peptide enhanced upregulation of adipocyte adiponectin production is a counter-regulatory effect in response to underlying endothelial dysfunction that is likely contributing to or associated with cardiac insufficiency. In support of this possible mechanistic link, the positive association we observed between plasma adiponectin and ADMA levels in this study population was not independent of plasma NT-proBNP levels, and in subgroup analysis, was preserved only in patients with above-median NT-proBNP levels alone.

    • Changes in the arginine methylation of organ proteins during the development of diabetes mellitus

      2011, Diabetes Research and Clinical Practice
      Citation Excerpt :

      Hyperglycemia can activate proinflammatory cytokines such as TNF-α that could impair endothelial function in DM [34]. Eid et al. [35] reported that TNF-α decreased DDAH activity in cultured human endothelial cells and promoted the accumulation of ADMA. DDAH is widely distributed in tissues, where two isoforms are expressed (types 1 and 2).

    • Post-challenge hyperglycaemia, nitric oxide production and endothelial dysfunction: The putative role of asymmetric dimethylarginine (ADMA)

      2011, Nutrition, Metabolism and Cardiovascular Diseases
      Citation Excerpt :

      This effect can be inhibited in a dose dependent manner by insulin and adiponectin which suggests that multiple mechanisms are involved. It is thought that adiponectin counteracts the TNFα induced accumulation of ADMA through the DDAH pathway [89]. Increased levels of ADMA have been found in both type 1 [86] and type 2 [90] diabetes.

    View all citing articles on Scopus
    View full text